Lessons Learned from FDA 483s on Poor SOP Revision Practices
In one 483, FDA noted that multiple versions of an SOP on sampling procedures were found on the same shared drive. Operators accessed different versions, leading to non-uniform practices in microbiological sampling.
Click to read the full article.